Esperion Therapeutics, Inc. (ESPR) CEO Sheldon Koenig on Q2 2021 Results – Earnings Call Transcript

August 3, 2021
4:43 pm

Esperion Therapeutics, Inc. (ESPR) CEO Sheldon Koenig on Q2 2021 Results – Earnings Call Transcript

Esperion Therapeutics, Inc. (ESPR) Q2 2021 Earnings Conference Call August 3, 2021 8:00 AM ET
Company Participants
Ben Church – Investor Relations & Corporate Communications
Sheldon Koenig – President & Chief Executive Officer
Joanne Foody – Chief Medical…

Click here to view the original article.

Global, Seeking Alpha

Share this article

Skydance Stock Value Plummets Due to Planned Price Adjustment

October 14, 2026

A New Visa Survey Says 56% of Americans Are Open to the Idea of Using Stablecoins. Here’s What Crypto Investors Need to Know.

October 14, 2026

Merck & Co Inc Stock (MRK) Moved Up by 3.73% on Oct 14: A Full Analysis

October 14, 2026

Crypto wallets expand into DeFi hubs as swaps and yield move in-app

October 14, 2026

AbbVie Inc Stock (ABBV) Moved Up by 3.36% on Oct 14: A Full Analysis

October 14, 2026

BitMEX Sued For £10M Over Unlicensed Crypto-Derivatives

October 14, 2026

Plunges Over 15% to Lowest Since Late July as DA Davidson Warns High Financing Costs Could Cause Total Loss for Shareholders

October 14, 2026

Russia’s A7 Fintech Launches International Crypto To Bank Payment Service

October 14, 2026